Inventor · disambiguated record
Suresh De Silva
Also filed as: DE SILVA SURESH
33 granted patents·30 pending applications·105 citations·filing 2016–2025
97Inventor score
Top patents by PatentIndex Score
63 records- 0197US10988517B2Heterodimeric proteins for modulating gamma delta T cellsSHATTUCK LABS INC·Filed 2020·Granted Apr 27, 2021·4 cites·18 claims
- 0296US11834488B2VSIG8-based chimeric proteinsSHATTUCK LABS INC·Filed 2021·Granted Dec 5, 2023·2 cites·19 claims
- 0396US11643447B2Heterodimeric proteins for modulating gamma delta T cellsSHATTUCK LABS INC·Filed 2022·Granted May 9, 2023·2 cites·19 claims
- 0496US11547742B1Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2021·Granted Jan 10, 2023·2 cites·20 claims
- 0596US10899817B2TIGIT- and light-based chimeric proteinsSHATTUCK LABS INC·Filed 2020·Granted Jan 26, 2021·3 cites·20 claims
- 0696US10183060B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2016·Granted Jan 22, 2019·15 cites·23 claims
- 0795US10995127B2Heterodimeric proteins and uses thereofSHATTUCK LABS INC·Filed 2019·Granted May 4, 2021·8 cites·14 claims
- 0895US10646545B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2018·Granted May 12, 2020·5 cites·23 claims
- 0994US12319742B1Antibodies that bind TNFRSF25SHATTUCK LABS INC·Filed 2025·Granted Jun 3, 2025·1 cites·17 claims
- 1094US11780897B2Heterodimeric proteins and uses thereofSHATTUCK LABS INC·Filed 2021·Granted Oct 10, 2023·2 cites·20 claims
- 1194US10927159B2TIGIT- and light-based chimeric proteinsSHATTUCK LABS INC·Filed 2020·Granted Feb 23, 2021·2 cites·26 claims
- 1294US10660936B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2018·Granted May 26, 2020·4 cites·23 claims
- 1394US10653748B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2019·Granted May 19, 2020·4 cites·20 claims
- 1493US11896618B2FLT3L-based chimeric proteinsSHATTUCK LABS INC·Filed 2020·Granted Feb 13, 2024·2 cites·3 claims
- 1593US10449233B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2018·Granted Oct 22, 2019·7 cites·25 claims
- 1693US10188701B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2017·Granted Jan 29, 2019·6 cites·23 claims
- 1792US11654180B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2020·Granted May 23, 2023·2 cites·23 claims
- 1891US11098093B2Heterodimeric proteins for modulating gamma delta T cellsSHATTUCK LABS INC·Filed 2020·Granted Aug 24, 2021·2 cites·16 claims
- 1991US10543253B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2018·Granted Jan 28, 2020·4 cites·25 claims
- 2091US10525102B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2018·Granted Jan 7, 2020·4 cites·25 claims
- 2191US10493128B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2018·Granted Dec 3, 2019·4 cites·25 claims
- 2290US11332509B2Methods of making and using extracellular domain-based chimeric proteinsSHATTUCK LABS INC·Filed 2018·Granted May 17, 2022·2 cites·20 claims
- 2390US10513548B2CSF1R-based chimeric proteinsSHATTUCK LABS INC·Filed 2018·Granted Dec 24, 2019·3 cites·16 claims
- 2490US10086042B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsHEAT BIOLOGICS INC·Filed 2017·Granted Oct 2, 2018·4 cites·23 claims
- 2589US2024368242A1Methods of making and using extracellular domain-based chimeric proteinsSHATTUCK LABS INC·Filed 2024·Application pending·0 cites
- 2688US11267857B2CSF1R-based chimeric proteinsSHATTUCK LABS INC·Filed 2019·Granted Mar 8, 2022·2 cites·18 claims
- 2788US11192934B2VSIG8-based chimeric proteinsSHATTUCK LABS INC·Filed 2019·Granted Dec 7, 2021·2 cites·10 claims
- 2888US2024190939A1Tigit- and light-based chimeric proteinsSHATTUCK LABS INC·Filed 2024·Application pending·0 cites
- 2987US11267856B2CSF1R-CD40L chimeric proteinsSHATTUCK LABS INC·Filed 2018·Granted Mar 8, 2022·2 cites·14 claims
- 3087US10780121B2FLT3L-based chimeric proteinsSHATTUCK LABS INC·Filed 2019·Granted Sep 22, 2020·2 cites·7 claims
- 3186US11192933B2VSIG8-based chimeric proteinsSHATTUCK LABS INC·Filed 2018·Granted Dec 7, 2021·2 cites·10 claims
- 3286US2025332219A1Compositions and methods for adjoining type i and type ii extracellular domains as heterologous chimeric proteinsKOPFKINO IP LLC·Filed 2024·Application pending·0 cites
- 3384US2024067698A1Vsig8-based chimeric proteinsSHATTUCK LABS INC·Filed 2023·Application pending·0 cites
- 3483US12071465B2Methods of making and using extracellular domain-based chimeric proteinsSHATTUCK LABS INC·Filed 2022·Granted Aug 27, 2024·0 cites·20 claims
- 3582US11548930B2Intratumoral vaccinationHEAT BIOLOGICS INC·Filed 2018·Granted Jan 10, 2023·1 cites·12 claims
- 3681US2022227831A1Tigit- and light-based chimeric proteinsSHATTUCK LABS INC·Filed 2022·Application pending·0 cites
- 3777US2023220030A1Heterodimeric proteins and uses thereofSHATTUCK LABS INC·Filed 2023·Application pending·0 cites
- 3876US2022144909A1Csf1r-based chimeric proteinsSHATTUCK LABS INC·Filed 2022·Application pending·0 cites
- 3973US12460010B2Antibodies that bind TNFRSF25SHATTUCK LABS INC·Filed 2025·Granted Nov 4, 2025·0 cites·14 claims
- 4072US2023303659A1Intratumoral vaccinationHEAT BIOLOGICS INC·Filed 2022·Application pending·0 cites
- 4171US2024011101A1Method of determining resistance to checkpoint inhibitor therapiesSHATTUCK LABS INC·Filed 2021·Application pending·0 cites
- 4271US2024016892A1Methods of treating cancer using tigit-and light-based chimeric proteinsSHATTUCK LABS INC·Filed 2021·Application pending·0 cites
- 4368US12178847B2Compositions and methods for adjoining type I and type II extracellular domains as heterologous chimeric proteinsKOPFKINO IP LLC·Filed 2020·Granted Dec 31, 2024·0 cites·18 claims
- 4468US2023045794A1Nk cell-directed chimeric proteinsSHATTUCK LABS INC·Filed 2022·Application pending·0 cites
- 4568US2024122983A1Flt3l-based chimeric proteinsSHATTUCK LABS INC·Filed 2023·Application pending·0 cites
- 4665US2021379153A1Combination therapies comprising sirp alpha-based chimeric proteinsSHATTUCK LABS INC·Filed 2019·Application pending·0 cites
- 4765US2022025000A1Heterodimeric proteins for modulating gamma delta t cellsSHATTUCK LABS INC·Filed 2021·Application pending·0 cites
- 4865US2021309744A1Combination therapies comprising pd-1-based chimeric proteinsSHATTUCK LABS INC·Filed 2019·Application pending·0 cites
- 4962US2020399344A1Nk cell-directed chimeric proteinsSHATTUCK LABS INC·Filed 2020·Application pending·0 cites
- 5061US2023048633A1Tgfbr2-based chimeric proteinsSHATTUCK LABS INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 63 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Suresh De Silva files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →